Gary A Lyons insider trades: Travere Therapeutics (TVTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
and 9 more companies
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | TVTX | ↓ Sell | 10,000 | $63.28 | $633K | Direct | Aug 19, 2026 (1d) |
| Apr 14, 2026 | TVTX | ↓ Sell | 8,000 | $41.07 | $329K | Direct | Apr 16, 2026 (2d) |
| Dec 3, 2025 | NBIX | ↓ Sell | 15,000 | $152.61 | $2.3M | Direct | Dec 4, 2025 (1d) |
| Oct 4, 2024 | TVTX | ↓ Sell | 40,000 | $14.73 | $589K | Direct | Oct 4, 2024 (0d) |
| Aug 13, 2024 | NBIX | ↓ Sell | 11,570 | $150.43 | $1.7M | Direct | Aug 15, 2024 (2d) |
| Jul 16, 2024 | NBIX | ↓ Sell | 930 | $150.03 | $140K | Direct | Jul 18, 2024 (2d) |
| May 14, 2024 | NBIX | ↓ Sell | 12,500 | $135.63 | $1.7M | Direct | May 16, 2024 (2d) |
| Dec 22, 2023 | NBIX | ↓ Sell | 10,000 | $130.04 | $1.3M | Direct | Dec 27, 2023 (5d) |
| Dec 1, 2023 | NBIX | ↓ Sell | 5,000 | $116.77 | $584K | Direct | Dec 5, 2023 (4d) |
| Sep 12, 2023 | NBIX | ↓ Sell | 5,000 | $115.02 | $575K | Direct | Sep 14, 2023 (2d) |
| Sep 1, 2023 | NBIX | ↓ Sell | 5,000 | $110.06 | $550K | Direct | Sep 6, 2023 (5d) |
| Oct 31, 2022 | NBIX | ↓ Sell | 15,000 | $114.76 | $1.7M | Direct | Nov 2, 2022 (2d) |
| Oct 4, 2022 | NBIX | ↓ Sell | 5,000 | $110.54 | $553K | Direct | Oct 5, 2022 (1d) |
| Apr 25, 2022 | NBIX | ↓ Sell | 15,000 | $92.76 | $1.4M | Direct | Apr 27, 2022 (2d) |
| Oct 7, 2021 | NBIX | ↓ Sell | 5,000 | $105.06 | $525K | Direct | Oct 12, 2021 (5d) |
| Jun 10, 2021 | NBIX | ↓ Sell | 10,000 | $100.27 | $1.0M | Direct | Jun 14, 2021 (4d) |
| Jan 26, 2021 | NBIX | ↓ Sell | 2,000 | $120.02 | $240K | Direct | Jan 27, 2021 (1d) |
| Nov 8, 2019 | NBIX | ↓ Sell | 5,000 | $110.00 | $550K | Direct | Nov 13, 2019 (5d) |
| Nov 1, 2019 | NBIX | ↓ Sell | 5,000 | $100.22 | $501K | Direct | Nov 5, 2019 (4d) |
| Jul 30, 2019 | NBIX | ↓ Sell | 10,000 | $92.07 | $921K | Direct | Jul 31, 2019 (1d) |
| Nov 2, 2018 | NBIX | ↓ Sell | 15,000 | $114.41 | $1.7M | Direct | Nov 5, 2018 (3d) |
| Jun 13, 2018 | NBIX | ↓ Sell | 15,000 | $99.24 | $1.5M | Direct | Jun 15, 2018 (2d) |
| Feb 15, 2018 | NBIX | ↓ Sell | 5,000 | $84.67 | $423K | Direct | Feb 20, 2018 (5d) |
| Feb 5, 2018 | NBIX | ↓ Sell | 5,000 | $83.08 | $415K | Direct | Feb 7, 2018 (2d) |
| Dec 1, 2017 | NBIX | ↓ Sell | 10,000 | $72.92 | $729K | Direct | Dec 5, 2017 (4d) |
| Dec 5, 2016 | VICL | ↓ Sell | 7,078 | $2.30 | $16K | Direct | Dec 7, 2016 (2d) |
| Jun 3, 2016 | VICL | ↑ Buy | 7,078 | $4.39 | $31K | Direct | Jun 6, 2016 (3d) |
| Sep 18, 2015 | NBIX | ↓ Sell | 15,000 | $54.89 | $823K | Direct | Sep 21, 2015 (3d) |
| Mar 24, 2015 | NBIX | ↓ Sell | 30,000 | $41.53 | $1.2M | Direct | Mar 24, 2015 (0d) |
| Sep 15, 2014 | NBIX | ↓ Sell | 20,000 | $15.66 | $313K | Direct | Sep 17, 2014 (2d) |
| May 23, 2013 | VICL | ↑ Buy | 5,953 | $0.01 | $60 | Direct | May 28, 2013 (5d) |
| May 24, 2012 | VICL | ↑ Buy | 7,328 | $0.01 | $73 | Direct | May 29, 2012 (5d) |
| May 26, 2011 | VICL | ↑ Buy | 18,750 | $0.01 | $188 | Direct | May 31, 2011 (5d) |
| May 25, 2010 | VICL | ↑ Buy | 18,750 | $0.01 | $188 | Direct | May 27, 2010 (2d) |
| Dec 5, 2005 | NBIX | ↓ Sell | 5,000 | $61.95 | $310K | Direct | Dec 5, 2005 (0d) |
| Nov 22, 2005 | NBIX | ↓ Sell | 5,000 | $61.78 | $309K | Direct | Nov 22, 2005 (0d) |
| Nov 18, 2005 | NBIX | ↓ Sell | 5,000 | $59.70 | $299K | Direct | Nov 21, 2005 (3d) |
| Nov 3, 2005 | NBIX | ↓ Sell | 10,000 | $56.28 | $563K | Direct | Nov 4, 2005 (1d) |
| Oct 28, 2005 | NBIX | ↓ Sell | 10,000 | $51.50 | $515K | Direct | Oct 31, 2005 (3d) |
| Sep 7, 2005 | NBIX | ↓ Sell | 10,000 | $49.00 | $490K | Direct | Sep 7, 2005 (0d) |
| Aug 18, 2005 | NBIX | ↓ Sell | 5,000 | $46.76 | $234K | Direct | Aug 22, 2005 (4d) |
| Jun 15, 2005 | NBIX | ↓ Sell | 5,000 | $39.70 | $199K | Direct | Jun 17, 2005 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About Gary A Lyons's insider trades
Gary A Lyons is an insider at Travere Therapeutics (TVTX). Since Jun 15, 2005, Gary has reported 5 open-market purchases worth $32K and 37 sales worth $27.9M on SEC Form 4. In the last 12 months: 3 sales ($3.3M).
Their filings also include grants and awards (99 filings), option exercises (32 filings), shares withheld for taxes (9 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.